Cell Isolation Market Estimated Number Of New Cancer Cases By States United States 2022
Cell Isolation Market Growth Driven by Increased Demand for Isolated Human Cells in Biopharmaceutical Development - Trends & Forecasts 2023-2028
September 29, 2023 07:33 ET | Research and Markets
Dublin, Sept. 29, 2023 (GLOBE NEWSWIRE) -- The "Cell Isolation Market Size & Share Analysis - Growth Trends & Forecasts (2023-2028)" report has been added to ResearchAndMarkets.com's...
Synlogic_Logo_Blue.png
Synlogic Announces Pricing of $21.0 Million Underwritten Public Offering
September 29, 2023 07:00 ET | Synlogic, Inc.
CAMBRIDGE, Mass., Sept. 29, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral, non-systemically absorbed biotherapeutics to...
Macomics.jpg
Macomics Expands in Edinburgh with Move to Roslin Innovation Centre and Announces Appointment of Professor Paul Crocker to SAB
September 29, 2023 04:00 ET | Macomics Limited
EDINBURGH and CAMBRIDGE, United Kingdom, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Macomics Ltd, a leader in macrophage drug discovery, continues its growth trajectory with expansion in Edinburgh into...
Madrigal logo.jpg
Madrigal Pharmaceuticals Announces Pricing of $500 Million Public Offering
September 28, 2023 22:30 ET | Madrigal Pharmaceuticals, Inc.
CONSHOHOCKEN, Pa., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL), a clinical-stage biopharmaceutical company pursuing novel therapeutics for nonalcoholic...
Madrigal logo.jpg
Madrigal Pharmaceuticals Announces Proposed Public Offering
September 28, 2023 16:01 ET | Madrigal Pharmaceuticals, Inc.
CONSHOHOCKEN, Pa., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL), a clinical-stage biopharmaceutical company pursuing novel therapeutics for nonalcoholic...
Gisele Deblandre Photo
Cell-Easy is pleased to welcome Mrs. Gisele Deblandre, formerly CSO at MaSTherCell, as Chief Scientific Officer
September 28, 2023 08:15 ET | CELL-EASY
Cell-Easy, a contract development and manufacturing organization (CDMO) in cell therapy, proudly announces the appointment of Mrs. Gisele Deblandre.
Cytokinetics_Logo_RGB (1).jpg
Cytokinetics Announces Call for Proposals for Its Sixth Annual Communications Grant Program
September 28, 2023 07:30 ET | Cytokinetics, Incorporated
Program to Provide $100,000 in Support of Communications and Outreach for Patient Advocacy Organizations Focused on Cardiovascular and Neuromuscular Diseases Deadline for Applications is November...
Athira Pharma Logo RGB@1200px.jpg
Athira Pharma to Participate in Upcoming October Conferences
September 28, 2023 07:00 ET | Athira Pharma, Inc.
BOTHELL, Wash., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal...
SK Biopharmaceutical
SK Biopharmaceuticals’ Proteovant Therapeutics Presents Preclinical Data on IKZF2 Protein Degrader Program and MOPED™ Molecular Glue Screening Platform at the 20th Annual Discovery on Target Conference
September 26, 2023 10:01 ET | SK Biopharmaceuticals Co., Ltd.
KOREA and KING OF PRUSSIA, Pa., Sept. 26, 2023 (GLOBE NEWSWIRE) -- SK Biopharmaceuticals, a global biotech focused on the research, development and commercialization of treatments for disorders of...
SHMNLogo.jpg
SOHM Announces Its Acquisition of ABBIE, a World-Class Gene-Editing Platform Which Can Deliver Genetic Payloads Using Non-Viral Vectors
September 26, 2023 09:30 ET | SOHM, Inc.
CHINO HILLS, Calif., Sept. 26, 2023 (GLOBE NEWSWIRE) -- via IBN -- SOHM, Inc. (OTC PINK: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs...